Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of KROS
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Keros Therapeutics Inc. stock upgraded from Strong Sell Candidate to Sell Candidate after Wednesday trading session.
(Updated on Jul 03, 2024)

Sell candidate since Jul 01, 2024 Loss -3.66% PDF

The Keros Therapeutics Inc. stock price fell by -1.49% on the last day (Wednesday, 3rd Jul 2024) from $42.81 to $42.17. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 2.51% from a day low at $42.06 to a day high of $43.12. The price has fallen in 6 of the last 10 days and is down by -5.55% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -225 thousand shares and in total, 105 thousand shares were bought and sold for approximately $4.41 million.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -28.42% during the next 3 months and, with a 90% probability hold a price between $28.09 and $34.34 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

KROS Signals & Forecast

There are few to no technical positive signals at the moment. The Keros Therapeutics Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $44.39 and $48.04. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, June 04, 2024, and so far it has fallen -14.86%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Keros Therapeutics Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.06 between high and low, or 2.51%. For the last week, the stock has had daily average volatility of 3.52%.

Keros Therapeutics Inc. is oversold on RSI14 (24). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (KROS) For The Upcoming Trading Day Of Friday 5th

For the upcoming trading day on Friday, 5th we expect Keros Therapeutics Inc. to open at $42.45, and during the day (based on 14 day Average True Range), to move between $40.12 and $44.22, which gives a possible trading interval of +/-$2.05 (+/-4.87%) up or down from last closing price. If Keros Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 9.74% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $44.58, some $2.41 (5.71%) from the current price of $42.17, our system finds the risk reward not very attractive.

Is Keros Therapeutics Inc. stock A Buy?

Keros Therapeutics Inc. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -3.643 Sell Candidate Upgraded

Predicted Opening Price for Keros Therapeutics Inc. of Friday, July 5, 2024

Fair opening price July 5, 2024 Current price
$42.45 ( 0.660%) $42.17

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for KROS

Fibonacci Support & Resistance Levels

Level Price
R3 43.50 3.16%
R2 43.10 2.21%
R1 42.85 1.62%
Price 42.17
S1 42.05 -0.296%
S2 41.80 -0.89%
S3 41.39 -1.84%

Accumulated Volume Support & Resistance Levels

Level Price
R3 46.44 10.13%
R2 45.70 8.37%
R1 44.58 5.71%
Price 42.17
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for Keros Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Keros Therapeutics Inc. is KROS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Keros Therapeutics Inc. Stock?
Keros Therapeutics Inc. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

How to buy Keros Therapeutics Inc. Stock?
Keros Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Keros Therapeutics Inc. Stock.

What's the current price of Keros Therapeutics Inc. Stock?
As of the end of day on the Jul 03, 2024, the price of an Keros Therapeutics Inc. (KROS) share was $42.17.

What is the 52-week high and low for Keros Therapeutics Inc. Stock?
The 52-week high for Keros Therapeutics Inc. Stock is $73.00 and the 52-week low is $27.03.

What is the market capitalization of Keros Therapeutics Inc. Stock?
As of the Jul 03, 2024, the market capitalization of Keros Therapeutics Inc. is 1.522B.

When is the next earnings date for Keros Therapeutics Inc.?
The upcoming earnings date for Keros Therapeutics Inc. is Aug 05, 2024.
Click to get the best stock tips daily for free!

About Keros Therapeutics Inc.

Keros Therapeutics. Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia in pat... KROS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT